Question
What are different phases in clinical evaluation of a drug in human beings?
Answer :
Word Count : 531
______ __________ _______ _______ ________.
_____ __________ _____ _____ _________ ________ __________ ________.
____ ______ __________ ___ __________ __________ ______.
_______ ________ ____ ________ __________ _________ ______ _________ ______ ______ _________ _____.
_______ ______ _______ _____ ______ _______ __________.
_________ _______ ___ _____ _____ __________ _____ ________ ________ _________.
____ _________ _________ _____ ___ __________ _________.
_______ _______ __________ _____ ____ __________.
_________ _________ ____ ____ ____ ______ _____ ____ _____ _______ ________ _______.
_________ ____ ________ _________ _____ ______ ____ __________ ___ __________ ____ __________.
____ ___ _______ _________ ___ ____ ________ ___ _______ ___ _____ _______.
___ ______ _______ ______ _______ ____ ___ __________.
_____ _________ ________ __________ ___.
________ __________ ____ ______ ______ __________ ___.
_______ _______ ________ _______ ________ __________ ________.
_____ _____ _________ _________ ________ ________ _______ _______ ___ ______ __________ _________.
_____ ______ ____ ______ _____ ____ ______ _________.
___ _________ _______ _____ ___ __________ ______.
___ ___ ________ _______ ________ _______ _________ _______ _______ ______.
_____ ________ ______ ________ _________ _______ _________.
__________ _______ ______ ___ ___ ________ _____ _______ ________.
______ ___ _______ _______ ________.
______ _____ _______ ______ _________ ______ ________ ____.
______ ____ _________ _____ _________ ___ _______ ___ ________ _______ __________.
___ ______ _____ ____ ________ _______ ___ ________.
_______ ________ ___ _________ ________ _________ _____ ________ ___.
__________ _________ ______ ___ _________ __________ _____ __________ _____ __________ _____.
_____ _______ ________ _____ ______ _____ ________ _______ _______ ______ __________ _________.
______ _______ ________ ________ ______ ___ ______ _____ _____.
__________ _____ ____ __________ _______ __________ __________ _________ __________ ___ _____.
__________ __________ ___ _______ ________ _______.
____ __________ _______ ______ ______ _______ ________ ______ ______ __________.
__________ ___ __________ ____ _____.
_______ _____ ______ ________ ____.
________ ___ _________ __________ ____ _______.
_______ _______ _______ ________ ______ _______ _______ __________ _______ ____ ______ ________.
______ _____ ________ __________ _____.
_____ _________ ______ _____ __________.
_________ ____ _______ ___ _______ ______ ______ ___ ______ ___.
___ _____ _______ ____ __________ _______ _______ ____ ______ _______.
________ ______ __________ _________ ______ ________ ______ _______ _________ _________ __________.
___ ________ _________ __________ __________ __________ ______.
______ ______ ________ ___ ___ __________ ________ ___ _________ _______ _________ ____.
__________ _______ __________ ________ ___ ___ _________ __________.
_________ ___ _____ ____ _________.
_________ _____ __________ _____ ________ ________ _____.
_____ _______ __________ ________.
Skip in 10
The clinical evaluation of a drug in human beings is a critical component of drug development and regulatory affairs, designed to ensure the safety, efficacy, and quality of a pharmaceutical product before it reaches the market. This evaluation is structured in a series of phases, each with specific objectives, methodologies, and regulatory requirements. Clinical trials in humans are generally divided into four main phases: Phase I, Phase II, Phase III, and Phase IV. Phase I trials are the first stage of testing a new drug in human subjects, typically involving a small group of healthy volunteers, usually between 20 to 100 participants. The primary objective of Phase I is to assess the safety profile of the drug, including tolerability, pharmacokinetics (absorption, distribution, metabolism, and excretion), and pharmacodynamics (the drug's effects on the body).
_______ ____ ___ __________ __________ ________ ______ _________.______ __________ _______ _______ ________.
_____ __________ _____ _____ _________ ________ __________ ________.
____ ______ __________ ___ __________ __________ ______.
_______ ________ ____ ________ __________ _________ ______ _________ ______ ______ _________ _____.
_______ ______ _______ _____ ______ _______ __________.
_________ _______ ___ _____ _____ __________ _____ ________ ________ _________.
____ _________ _________ _____ ___ __________ _________.
_______ _______ __________ _____ ____ __________.
_________ _________ ____ ____ ____ ______ _____ ____ _____ _______ ________ _______.
_________ ____ ________ _________ _____ ______ ____ __________ ___ __________ ____ __________.
____ ___ _______ _________ ___ ____ ________ ___ _______ ___ _____ _______.
___ ______ _______ ______ _______ ____ ___ __________.
_____ _________ ________ __________ ___.
________ __________ ____ ______ ______ __________ ___.
_______ _______ ________ _______ ________ __________ ________.
_____ _____ _________ _________ ________ ________ _______ _______ ___ ______ __________ _________.
_____ ______ ____ ______ _____ ____ ______ _________.
___ _________ _______ _____ ___ __________ ______.
___ ___ ________ _______ ________ _______ _________ _______ _______ ______.
_____ ________ ______ ________ _________ _______ _________.
__________ _______ ______ ___ ___ ________ _____ _______ ________.
______ ___ _______ _______ ________.
______ _____ _______ ______ _________ ______ ________ ____.
______ ____ _________ _____ _________ ___ _______ ___ ________ _______ __________.
___ ______ _____ ____ ________ _______ ___ ________.
_______ ________ ___ _________ ________ _________ _____ ________ ___.
__________ _________ ______ ___ _________ __________ _____ __________ _____ __________ _____.
_____ _______ ________ _____ ______ _____ ________ _______ _______ ______ __________ _________.
______ _______ ________ ________ ______ ___ ______ _____ _____.
__________ _____ ____ __________ _______ __________ __________ _________ __________ ___ _____.
__________ __________ ___ _______ ________ _______.
____ __________ _______ ______ ______ _______ ________ ______ ______ __________.
__________ ___ __________ ____ _____.
_______ _____ ______ ________ ____.
________ ___ _________ __________ ____ _______.
_______ _______ _______ ________ ______ _______ _______ __________ _______ ____ ______ ________.
______ _____ ________ __________ _____.
_____ _________ ______ _____ __________.
_________ ____ _______ ___ _______ ______ ______ ___ ______ ___.
___ _____ _______ ____ __________ _______ _______ ____ ______ _______.
________ ______ __________ _________ ______ ________ ______ _______ _________ _________ __________.
___ ________ _________ __________ __________ __________ ______.
______ ______ ________ ___ ___ __________ ________ ___ _________ _______ _________ ____.
__________ _______ __________ ________ ___ ___ _________ __________.
_________ ___ _____ ____ _________.
_________ _____ __________ _____ ________ ________ _____.
_____ _______ __________ ________.
IGNOU ACADEMY
Your IGNOU journey, made easier.
- Solved Assignments
- Study Notes
- Guess Papers
- Question Papers
Continue Reading — It's Free
Sign in with Google to unlock more of this answer.
✓ Free access
✓ Unlock up to 60% of the answer
✓ No payment required
✓ Unlock up to 60% of the answer
✓ No payment required
Quick Google sign-in. No separate registration form.